ArticleThe Journal of experimental medicine2018

Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.

Ying Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.